Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
91
Views
8
CrossRef citations to date
0
Altmetric
Original Research

The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice

Liang-Jian Hong1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of China
,
Ai-Jun Chen1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of China
,
Feng-Zeng Li1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of China
,
Ke-Jun Chen1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of China
&
Sheng Fang1 Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People’s Republic of ChinaCorrespondence[email protected]
Pages 4605-4612 | Published online: 29 Oct 2020

References

  • LiJ, BuchnerJ. Structure, function and regulation of the HSP90 machinery. Biomed J. 2013;36(3):106–117.23806880
  • ProdromouC. Mechanisms of HSP90 regulation. Biochem J. 2016;473(16):2439–2452. doi:10.1042/BCJ2016000527515256
  • ZiningaT, RamatsuiL, ShonhaiA. Heat shock proteins as immunomodulant. Molecules. 2018;23(11):2846. doi:10.3390/molecules23112846
  • TsanMF, GaoB. Heat shock protein and innate immunity. Cell Mol Immunol. 2004;1(4):274–279.16225770
  • WangY, McAlpineSR. Heat-shock protein 90 inhibitors: will they ever succeed as chemotherapeutics? Future Med Chem. 2015;7(2):87–90. doi:10.4155/fmc.14.15425685998
  • DasJK, XiongX, RenX, YangJM, SongJ. Heat shock proteins in cancer immunotherapy. J Oncol. 2019;2019:3267207. doi:10.1155/2019/326720731885572
  • SaitoK, KukitaK, KutomiG, et al. Heat shock protein 90 associates with toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur J Immunol. 2015;45(7):2028–2041. doi:10.1002/eji.20144529325871979
  • ShuklaHD, PithaPM. Role of HSP90 in systemic lupus erythematosus and its clinical relevance. Autoimmune Dis. 2012;2012:728605.23091704
  • KenderovA, MinkovaV, MihailovaD, et al. Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies. Clin Exp Immunol. 2002;129(1):169–176. doi:10.1046/j.1365-2249.2002.01887.x12100037
  • RipleyBJ, IsenbergDA, LatchmanDS. Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90. J Autoimmun. 2001;17(4):341–346. doi:10.1006/jaut.2001.054911771959
  • DhillonVB, McCallumS, NortonP, et al. Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus. Ann Rheum Dis. 1993;52(6):436–442. doi:10.1136/ard.52.6.4368323395
  • YunTJ, HarningEK, GizaK, et al. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity. J Immunol. 2011;186(1):563–575. doi:10.4049/jimmunol.100022221131419
  • PoulakiV, IliakiE, MitsiadesN, et al. Inhibition of HSP90 attenuates inflammation in endotoxin-induced uveitis. FASEB J. 2007;21(9):2113–2123. doi:10.1096/fj.06-7637com17400913
  • Dello RussoC, PolakPE, MercadoPR, et al. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem. 2006;99(5):1351–1362. doi:10.1111/j.1471-4159.2006.04221.x17064348
  • LiuY, YeJ, Shin OgawaL, et al. The HSP90 inhibitor ganetespib alleviates disease progression and augments intermittent cyclophosphamide therapy in the MRL/lpr mouse model of systemic lupus erythematosus. PLoS One. 2015;10(5):e0127361. doi:10.1371/journal.pone.012736125974040
  • TomkowiczB, WalshE, CottyA, et al. TIM-3 suppresses anti-CD3/CD28-induced TCR activation and IL-2 expression through the NFAT signaling pathway. PLoS One. 2015;10(10):e0140694. doi:10.1371/journal.pone.014069426492563
  • CibriánD, Sánchez-MadridF. CD69: from activation marker to metabolic gatekeeper. Eur J Immunol. 2017;47(6):946–953.28475283
  • LiuK, JinH, GuoY, et al. CFTR interacts with HSP90 and regulates the phosphorylation of AKT and ERK1/2 in colorectal cancer cells. FEBS Open Bio. 2019;9(6):1119–1127. doi:10.1002/2211-5463.12641
  • AbeyrathnaP, SuY. The critical role of AKT in cardiovascular function. Vascul Pharmacol. 2015;74:38–48. doi:10.1016/j.vph.2015.05.00826025205
  • LinJX, XieXS, WengXF, et al. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway. Oncol Rep. 2019;41(5):2739–2752.30864700

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.